Indications -- Psoriasis/Chronic Inflammation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (573)	4/4/2007 10:53:39 AM
From: software salesperson	of 631

Name Company Delivery Mechanism Mechanism of Action Phase Indication ABT-874 Abbott Immunology injectable IL-12/IL-23 inhibitor II psoriasis AS210 (Psoraxine) Astralis, LTD. injectable anti-inflammatory agent II psoriasis Becocalcidiol (Asord) QuatRx Pharmaceuticals Co. topical vitamin D analog II psoriasis Bimosiamose Revotar BioPharmaceuticals AG topical cell migration inhibitor II psoriasis BIRT 2584 XX Boehringer Ingelheim Pharmaceuticals oral anti-inflammatory agent II psoriasis BMS-582949 Bristol-Myers Squibb oral anti-inflammatory agent II psoriasis CC-10004 Celgene oral TNF-alpha inhibitor II psoriasis CEP-701 Cephalon oral anti-inflammatory agent II psoriasis Certolizumab pegol (Cimzia) UCB injectable TNF-alpha inhibitor II psoriasis CH-1504 Chelsea Therapeutics International, Ltd. oral anti-inflammatory agent II psoriasis CNTO 1275 Centocor, Inc. injectable IL-12/IL-23 inhibitor II psoriatic arthritis CTA018 Cytochroma Inc. topical vitamin D analog II psoriasis CTAR398 Cytochroma Inc. topical vitamin D analog II psoriasis MM-093 Merrimack Pharmaceuticals oral anti-inflammatory agent II psoriasis Rambazole Barrier Therapeutics oral retinoid II psoriasis RWJ-445380 Alza Corp. oral anti-inflammatory agent II psoriasis TGAAC94 Targeted Genetics Corp. injectable TNF-alpha inhibitor II psoriatic arthritis Adalimumab (Humira) Abbott Immunology injectable TNF-alpha inhibitor III psoriasis BG-12 Biogen Idec oral fumaric acid ester III psoriasis CNTO 1275 Centocor, Inc. injectable IL-12/IL-23 inhibitor III psoriasis CNTO 148 (golimumab) Centocor, Inc. injectable TNF-alpha inhibitor III psoriatic arthritis Fumaderm Biogen Idec oral fumaric acid ester III psoriasis ISA247 Isotechnika oral anti-inflammatory agent III psoriasis Recent approvals Calcipotriene/beta-methasone dipropionate (Taclonex) Warner Chilcott topical anti-inflammatory and cell growth inhibitor approved psoriasis Infliximab (Remicade) Centocor, Inc. infusion TNF-alpha inhibitor approved psoriasis Compiled and updated by the National Psoriasis Foundation, March 2007

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next